AACAP 2002 research forum: Placebo and alternatives to placebo in randomized controlled trials in pediatric psychopharmacology

John March, Christopher J Kratochvil, Gregory Clarke, William Beardslee, Albert Derivan, Graham Emslie, Evelyn P. Green, John Heiligenstein, Stephen Hinshaw, Kimberly Hoagwood, Peter Jensen, Philip Lavori, Henrietta Leonard, James McNulty, M. Alex Michaels, Andrew Mossholder, Trina Osher, Theodore Petti, Ernest Prentice, Benedetto VitielloKaren Wells

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Objective: The use of placebo in the pediatric age group has come under increasing scrutiny. At the 2002 Annual Meeting of the American Academy of Child and Adolescent Psychiatry, the Academy's Workgroup on Research conducted a research forum. The purpose was to identify challenges and their solutions regarding the use of placebo in randomized controlled trials in pediatric psychopharmacology. Method: Workgroups focused on problems and solutions in five areas: ethics and human subjects, research design and statistics, partnering with consumers, U.S. Food and Drug Administration and pharmaceutical industry perspectives, and psychosocial treatments. Results: In many but not all circumstances, inclusion of a placebo control is essential to meet the scientific goals of treatment outcome research. Innovative research designs; involvement of consumers in planning and implementing research; flexibility by industry, academia, the National Institutes of Health, and regulatory agencies acting in partnership; and concomitant use of evidence-based psychosocial services can and should assist in making placebo-controlled trials acceptable. Conclusions: Properly designed placebo-controlled trials remain necessary, ethical, and feasible.

Original languageEnglish (US)
Pages (from-to)1046-1056
Number of pages11
JournalJournal of the American Academy of Child and Adolescent Psychiatry
Volume43
Issue number8
DOIs
StatePublished - Aug 2004

Fingerprint

Psychopharmacology
Randomized Controlled Trials
Placebos
Pediatrics
Research
Drug Industry
Research Design
Adolescent Psychiatry
Child Psychiatry
National Institutes of Health (U.S.)
Ethics
Industry
Age Groups
Outcome Assessment (Health Care)
Food

Keywords

  • Adolescence
  • Placebo
  • Psychopharmacology
  • Randomized controlled trial
  • Treatment

ASJC Scopus subject areas

  • Developmental and Educational Psychology
  • Psychiatry and Mental health

Cite this

AACAP 2002 research forum : Placebo and alternatives to placebo in randomized controlled trials in pediatric psychopharmacology. / March, John; Kratochvil, Christopher J; Clarke, Gregory; Beardslee, William; Derivan, Albert; Emslie, Graham; Green, Evelyn P.; Heiligenstein, John; Hinshaw, Stephen; Hoagwood, Kimberly; Jensen, Peter; Lavori, Philip; Leonard, Henrietta; McNulty, James; Michaels, M. Alex; Mossholder, Andrew; Osher, Trina; Petti, Theodore; Prentice, Ernest; Vitiello, Benedetto; Wells, Karen.

In: Journal of the American Academy of Child and Adolescent Psychiatry, Vol. 43, No. 8, 08.2004, p. 1046-1056.

Research output: Contribution to journalArticle

March, J, Kratochvil, CJ, Clarke, G, Beardslee, W, Derivan, A, Emslie, G, Green, EP, Heiligenstein, J, Hinshaw, S, Hoagwood, K, Jensen, P, Lavori, P, Leonard, H, McNulty, J, Michaels, MA, Mossholder, A, Osher, T, Petti, T, Prentice, E, Vitiello, B & Wells, K 2004, 'AACAP 2002 research forum: Placebo and alternatives to placebo in randomized controlled trials in pediatric psychopharmacology', Journal of the American Academy of Child and Adolescent Psychiatry, vol. 43, no. 8, pp. 1046-1056. https://doi.org/10.1097/01.chi.0000129606.83206.77
March, John ; Kratochvil, Christopher J ; Clarke, Gregory ; Beardslee, William ; Derivan, Albert ; Emslie, Graham ; Green, Evelyn P. ; Heiligenstein, John ; Hinshaw, Stephen ; Hoagwood, Kimberly ; Jensen, Peter ; Lavori, Philip ; Leonard, Henrietta ; McNulty, James ; Michaels, M. Alex ; Mossholder, Andrew ; Osher, Trina ; Petti, Theodore ; Prentice, Ernest ; Vitiello, Benedetto ; Wells, Karen. / AACAP 2002 research forum : Placebo and alternatives to placebo in randomized controlled trials in pediatric psychopharmacology. In: Journal of the American Academy of Child and Adolescent Psychiatry. 2004 ; Vol. 43, No. 8. pp. 1046-1056.
@article{f6c530c91ba74f1ba650d21b11f2e397,
title = "AACAP 2002 research forum: Placebo and alternatives to placebo in randomized controlled trials in pediatric psychopharmacology",
abstract = "Objective: The use of placebo in the pediatric age group has come under increasing scrutiny. At the 2002 Annual Meeting of the American Academy of Child and Adolescent Psychiatry, the Academy's Workgroup on Research conducted a research forum. The purpose was to identify challenges and their solutions regarding the use of placebo in randomized controlled trials in pediatric psychopharmacology. Method: Workgroups focused on problems and solutions in five areas: ethics and human subjects, research design and statistics, partnering with consumers, U.S. Food and Drug Administration and pharmaceutical industry perspectives, and psychosocial treatments. Results: In many but not all circumstances, inclusion of a placebo control is essential to meet the scientific goals of treatment outcome research. Innovative research designs; involvement of consumers in planning and implementing research; flexibility by industry, academia, the National Institutes of Health, and regulatory agencies acting in partnership; and concomitant use of evidence-based psychosocial services can and should assist in making placebo-controlled trials acceptable. Conclusions: Properly designed placebo-controlled trials remain necessary, ethical, and feasible.",
keywords = "Adolescence, Placebo, Psychopharmacology, Randomized controlled trial, Treatment",
author = "John March and Kratochvil, {Christopher J} and Gregory Clarke and William Beardslee and Albert Derivan and Graham Emslie and Green, {Evelyn P.} and John Heiligenstein and Stephen Hinshaw and Kimberly Hoagwood and Peter Jensen and Philip Lavori and Henrietta Leonard and James McNulty and Michaels, {M. Alex} and Andrew Mossholder and Trina Osher and Theodore Petti and Ernest Prentice and Benedetto Vitiello and Karen Wells",
year = "2004",
month = "8",
doi = "10.1097/01.chi.0000129606.83206.77",
language = "English (US)",
volume = "43",
pages = "1046--1056",
journal = "Journal of the American Academy of Child and Adolescent Psychiatry",
issn = "0890-8567",
publisher = "Elsevier Limited",
number = "8",

}

TY - JOUR

T1 - AACAP 2002 research forum

T2 - Placebo and alternatives to placebo in randomized controlled trials in pediatric psychopharmacology

AU - March, John

AU - Kratochvil, Christopher J

AU - Clarke, Gregory

AU - Beardslee, William

AU - Derivan, Albert

AU - Emslie, Graham

AU - Green, Evelyn P.

AU - Heiligenstein, John

AU - Hinshaw, Stephen

AU - Hoagwood, Kimberly

AU - Jensen, Peter

AU - Lavori, Philip

AU - Leonard, Henrietta

AU - McNulty, James

AU - Michaels, M. Alex

AU - Mossholder, Andrew

AU - Osher, Trina

AU - Petti, Theodore

AU - Prentice, Ernest

AU - Vitiello, Benedetto

AU - Wells, Karen

PY - 2004/8

Y1 - 2004/8

N2 - Objective: The use of placebo in the pediatric age group has come under increasing scrutiny. At the 2002 Annual Meeting of the American Academy of Child and Adolescent Psychiatry, the Academy's Workgroup on Research conducted a research forum. The purpose was to identify challenges and their solutions regarding the use of placebo in randomized controlled trials in pediatric psychopharmacology. Method: Workgroups focused on problems and solutions in five areas: ethics and human subjects, research design and statistics, partnering with consumers, U.S. Food and Drug Administration and pharmaceutical industry perspectives, and psychosocial treatments. Results: In many but not all circumstances, inclusion of a placebo control is essential to meet the scientific goals of treatment outcome research. Innovative research designs; involvement of consumers in planning and implementing research; flexibility by industry, academia, the National Institutes of Health, and regulatory agencies acting in partnership; and concomitant use of evidence-based psychosocial services can and should assist in making placebo-controlled trials acceptable. Conclusions: Properly designed placebo-controlled trials remain necessary, ethical, and feasible.

AB - Objective: The use of placebo in the pediatric age group has come under increasing scrutiny. At the 2002 Annual Meeting of the American Academy of Child and Adolescent Psychiatry, the Academy's Workgroup on Research conducted a research forum. The purpose was to identify challenges and their solutions regarding the use of placebo in randomized controlled trials in pediatric psychopharmacology. Method: Workgroups focused on problems and solutions in five areas: ethics and human subjects, research design and statistics, partnering with consumers, U.S. Food and Drug Administration and pharmaceutical industry perspectives, and psychosocial treatments. Results: In many but not all circumstances, inclusion of a placebo control is essential to meet the scientific goals of treatment outcome research. Innovative research designs; involvement of consumers in planning and implementing research; flexibility by industry, academia, the National Institutes of Health, and regulatory agencies acting in partnership; and concomitant use of evidence-based psychosocial services can and should assist in making placebo-controlled trials acceptable. Conclusions: Properly designed placebo-controlled trials remain necessary, ethical, and feasible.

KW - Adolescence

KW - Placebo

KW - Psychopharmacology

KW - Randomized controlled trial

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=3242796813&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3242796813&partnerID=8YFLogxK

U2 - 10.1097/01.chi.0000129606.83206.77

DO - 10.1097/01.chi.0000129606.83206.77

M3 - Article

C2 - 15266201

AN - SCOPUS:3242796813

VL - 43

SP - 1046

EP - 1056

JO - Journal of the American Academy of Child and Adolescent Psychiatry

JF - Journal of the American Academy of Child and Adolescent Psychiatry

SN - 0890-8567

IS - 8

ER -